Gene · 5921
NIH grants2,330
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,421 to 1,440 of 2,330
Download this page as JSON| Grant | Title | RASA1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA107263 | Integrins and Caspase 8 in Tumor Progression | 1 | 2014 |
| R01CA112270 | Clinically relevant molecular subtypes in leiomyosarcoma | 1 | 2014 |
| R01CA113733 | Molecular Function of the Nf2 Tumor Suppressor, Merlin | 1 | 2014 |
| R01CA120247 | Mutant EGF Receptor-Dependent Lung Cancer in Human Cell Lines and Transgenic Mice | 1 | 2014 |
| R01CA134604 | Investigating Oncogenic Cooperation between BMI-1 and EWS-FLI1 | 1 | 2014 |
| R01CA135242 | Multifunctional nanoparticles for targeting aberrant tumorigenic pathways | 1 | 2014 |
| R01CA139099 | Molecular Combinatorial Therapy of Glioblastoma Multiforme | 1 | 2014 |
| R01CA140424 | Targeting Ras-Ral GEF-Ral Effector Signaling for Pancreatic Cancer Treatment | 1 | 2014 |
| R01CA142787 | Role of DOK family proteins in lung tumor suppression | 1 | 2014 |
| R01CA143081 | Tetraspanin-mediated regulation of tumor cell migration and metastasis | 1 | 2014 |
| R01CA152194 | Small Molecule Inhibitors for the Oncogenic Protein Tyrosine Phosphatase SHP2 | 1 | 2014 |
| R01CA152371 | Akt-EphA2 Crosstalk in Glioma Invasion | 1 | 2014 |
| R01CA152975 | Mechanism of Merlin-mediated contact inhibition and tumor suppression. | 1 | 2014 |
| R01CA155019 | Molecular Mechanism of miR-140 in Colon Cancer | 1 | 2014 |
| R01CA160736 | Integrative methods for high-dimensional genomics data | 1 | 2014 |
| R01CA173592 | Maximizing effectiveness of radioiodine therapy by inhibition of MAPK signaling | 1 | 2014 |
| R01DK069370 | Mechanisms of survival signaling in biliary epithelia | 1 | 2014 |
| R01DK084910 | Renin Angioensin Aldosterone System in Drub Abuse and HIV-associated Nephropathy | 1 | 2014 |
| R01ES018948 | Linkage of Lung Inflammation to 8-oxoguanine and OGG1 | 1 | 2014 |
| R01EY013435 | Genetic Susceptibility to Age-Related Macular Degeneration | 1 | 2014 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5921/grants?page=72